The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...

A vaccine for pregnant women, which can protect their infants from the RSV illness after birth, has been approved by the U.S. Food and Drug Administration. The FDA recently approved Abrysvo, a ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. RSV is a disease that’s common in children. Severe RSV can require hospitalization, oxygen supplementation, and ...

GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Arexvy (respiratory syncytial virus ...

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...

Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ...

Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.

GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...